Literature DB >> 18962897

Structural features of T cell receptor variable regions that enhance domain stability and enable expression as single-chain ValphaVbeta fragments.

Sarah A Richman1, David H Aggen, Michelle L Dossett, David L Donermeyer, Paul M Allen, Philip D Greenberg, David M Kranz.   

Abstract

The variable (V) domains of antibodies and T cell receptors (TCRs) share sequence homology and striking structural similarity. Single-chain antibody V domain constructs (scFv) are routinely expressed in a variety of heterologous systems, both for production of soluble protein as well as for in vitro engineering. In contrast, single-chain T cell receptor V domain constructs (scTCR) are prone to aggregation and misfolding and are refractory to display on phage or yeast in their wild-type form. However, through random mutagenesis and yeast display engineering, it has been possible to isolate scTCR mutants that are properly folded and displayed on the yeast surface. These displayed mutants can serve not only as a scaffold for further engineering but also as scTCR variants that exhibit favorable biophysical properties in Escherichia coli expression. Thus, a more comprehensive understanding of the V domain mutations that allowed display would be beneficial. Our goal here was to identify generalizable patterns of important mutations that can be applied to different TCRs. We compared five different scTCRs, four from mice and one from a human, for yeast surface display. Analysis of a collection of mutants revealed four distinct regions of TCR V domains that were most important for enabling surface expression: the Valpha-Vbeta interface, the HV4 of Vbeta, and the region of the Valpha and Vbeta domains normally apposed against the constant (C) domains. Consistent with the role of the V-C interface in surface display, reconstitution of this interface, by including the constant domains of each chain, allowed V domain display and alphabeta chain association on the yeast surface, thus providing an alternative TCR scaffold. However, the surface levels of TCR achieved with engineered scTCR mutants were superior to that of the ValphaCalpha/VbetaCbeta constructs. Therefore, we describe further optimization of the current strategy for surface display of the single-chain format in order to facilitate yeast display engineering of a broader range of scTCRs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18962897      PMCID: PMC2666936          DOI: 10.1016/j.molimm.2008.09.021

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  64 in total

Review 1.  Selecting and screening recombinant antibody libraries.

Authors:  Hennie R Hoogenboom
Journal:  Nat Biotechnol       Date:  2005-09       Impact factor: 54.908

2.  Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1.

Authors:  Rebecca A Buonpane; Beenu Moza; Eric J Sundberg; David M Kranz
Journal:  J Mol Biol       Date:  2005-10-21       Impact factor: 5.469

3.  High-level bacterial secretion of single-chain alphabeta T-cell receptors.

Authors:  Jennifer Maynard; Erin J Adams; Michelle Krogsgaard; Karin Petersson; Corey W Liu; K Christopher Garcia
Journal:  J Immunol Methods       Date:  2005-09-12       Impact factor: 2.303

Review 4.  How TCRs bind MHCs, peptides, and coreceptors.

Authors:  Markus G Rudolph; Robyn L Stanfield; Ian A Wilson
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

5.  How a single T cell receptor recognizes both self and foreign MHC.

Authors:  Leremy A Colf; Alexander J Bankovich; Nicole A Hanick; Natalie A Bowerman; Lindsay L Jones; David M Kranz; K Christopher Garcia
Journal:  Cell       Date:  2007-04-06       Impact factor: 41.582

6.  A new twist in TCR diversity revealed by a forbidden alphabeta TCR.

Authors:  Christine McBeth; Audrey Seamons; Juan C Pizarro; Sarel J Fleishman; David Baker; Tanja Kortemme; Joan M Goverman; Roland K Strong
Journal:  J Mol Biol       Date:  2007-11-17       Impact factor: 5.469

7.  Class II-restricted T cell receptor engineered in vitro for higher affinity retains peptide specificity and function.

Authors:  K Scott Weber; David L Donermeyer; Paul M Allen; David M Kranz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

8.  Directed evolution of human T-cell receptors with picomolar affinities by phage display.

Authors:  Yi Li; Ruth Moysey; Peter E Molloy; Anne-Lise Vuidepot; Tara Mahon; Emma Baston; Steven Dunn; Nathaniel Liddy; Jansen Jacob; Bent K Jakobsen; Jonathan M Boulter
Journal:  Nat Biotechnol       Date:  2005-02-20       Impact factor: 54.908

9.  Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes.

Authors:  Nathalie Demotte; Vincent Stroobant; Pierre J Courtoy; Patrick Van Der Smissen; Didier Colau; Immanuel F Luescher; Claire Hivroz; Julie Nicaise; Jean-Luc Squifflet; Michel Mourad; Danièle Godelaine; Thierry Boon; Pierre van der Bruggen
Journal:  Immunity       Date:  2008-03       Impact factor: 31.745

10.  In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naïve repertoire.

Authors:  William Y Ho; Hieu N Nguyen; Matthias Wolfl; Juergen Kuball; Philip D Greenberg
Journal:  J Immunol Methods       Date:  2006-01-26       Impact factor: 2.303

View more
  26 in total

1.  Identification and engineering of human variable regions that allow expression of stable single-chain T cell receptors.

Authors:  David H Aggen; Adam S Chervin; Francis K Insaidoo; Kurt H Piepenbrink; Brian M Baker; David M Kranz
Journal:  Protein Eng Des Sel       Date:  2010-12-14       Impact factor: 1.650

2.  Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chains.

Authors:  D H Aggen; A S Chervin; T M Schmitt; B Engels; J D Stone; S A Richman; K H Piepenbrink; B M Baker; P D Greenberg; H Schreiber; D M Kranz
Journal:  Gene Ther       Date:  2011-07-14       Impact factor: 5.250

3.  Characterization of the Staphylococcal enterotoxin A: Vβ receptor interaction using human receptor fragments engineered for high affinity.

Authors:  P Sharma; S Postel; E J Sundberg; D M Kranz
Journal:  Protein Eng Des Sel       Date:  2013-10-27       Impact factor: 1.650

4.  T Cell Receptor Engineering and Analysis Using the Yeast Display Platform.

Authors:  Sheena N Smith; Daniel T Harris; David M Kranz
Journal:  Methods Mol Biol       Date:  2015

5.  Subtle changes at the variable domain interface of the T-cell receptor can strongly increase affinity.

Authors:  Preeti Sharma; David M Kranz
Journal:  J Biol Chem       Date:  2017-12-11       Impact factor: 5.157

6.  Comparison of T Cell Activities Mediated by Human TCRs and CARs That Use the Same Recognition Domains.

Authors:  Daniel T Harris; Marlies V Hager; Sheena N Smith; Qi Cai; Jennifer D Stone; Philipp Kruger; Melissa Lever; Omer Dushek; Thomas M Schmitt; Philip D Greenberg; David M Kranz
Journal:  J Immunol       Date:  2017-12-29       Impact factor: 5.422

7.  A TCRα framework-centered codon shapes a biased T cell repertoire through direct MHC and CDR3β interactions.

Authors:  Kristin Støen Gunnarsen; Lene Støkken Høydahl; Louise Fremgaard Risnes; Shiva Dahal-Koirala; Ralf Stefan Neumann; Elin Bergseng; Terje Frigstad; Rahel Frick; M Fleur du Pré; Bjørn Dalhus; Knut Ea Lundin; Shuo-Wang Qiao; Ludvig M Sollid; Inger Sandlie; Geir Åge Løset
Journal:  JCI Insight       Date:  2017-09-07

8.  Increased Fab thermoresistance via VH-targeted directed evolution.

Authors:  Kevin C Entzminger; Jennifer L Johnson; Jeongmin Hyun; Raquel L Lieberman; Jennifer A Maynard
Journal:  Protein Eng Des Sel       Date:  2015-08-16       Impact factor: 1.650

9.  Periplasmic expression of soluble single chain T cell receptors is rescued by the chaperone FkpA.

Authors:  Kristin S Gunnarsen; Elin Lunde; Per E Kristiansen; Bjarne Bogen; Inger Sandlie; Geir Å Løset
Journal:  BMC Biotechnol       Date:  2010-02-03       Impact factor: 2.563

10.  A novel T cell receptor single-chain signaling complex mediates antigen-specific T cell activity and tumor control.

Authors:  Jennifer D Stone; Daniel T Harris; Carolina M Soto; Adam S Chervin; David H Aggen; Edward J Roy; David M Kranz
Journal:  Cancer Immunol Immunother       Date:  2014-08-01       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.